Prognostic Impact of the Evolution of PAH 3 Months After TAVI (HTP-TAVI)

Phase

TERMINATED

Status

101

Enrollment

OTHER

Sponsor class

Stopped * Delay in enrolment (24% at 1 year) * Lower than estimated prevalence of PAH (15% instead of 50%) * Refusal of patients with PAH to participate

Conditions

Aortic Valve Stenosis
Pulmonary Hypertension

Interventions

PROCEDURE: Right Heart Catheterization

Sponsor

University Hospital, Rouen